Back to search

United Kingdom· GB-APID-3963811000001100

Ferriprox 500mg tablets

A deferiprone product containing deferiprone, registered in United Kingdom by Chiesi Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC V03AC02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFerriprox 500mg tabletsATCV03AC02REGISTER NO.GB-APID-3963811000001…PACKS LISTED3CHECKEDSeptember 13, 2026

Where it is registered

Deferiprone is registered in 16 of 19 countries.

Countries holding a registration under ATC V03AC02 (deferiprone), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Deferiprone · ATC V03AC02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferiprone costs, country by country.

Normalised to the WHO defined daily dose (5.25 g), the median price runs from $22.61 in Switzerland to $8636.08 in Italy — a ×382 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Deferiprone · price per daily dose (5.25 g)

USD · FX 28 Sept 2026

  • IT Italy$8636.08
  • CH Switzerland$22.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Deferiprone
Manufacturer
Chiesi Ltd
Country
United Kingdom (GB)
ATC code
V03AC02
ATC class
Deferiprone
Defined daily dose
5.25 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    0771313142915
  • gtin
    03400936576285
  • gtin
    3400936576285

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

315 interactions on record for deferiprone.

Graded by severity as the source publishes them — 266 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Deferiprone · interactions on record

315 records

  • 266 severe
  • 49 moderate

Most severe, free to view

  • FostamatinibB02BX09severe
  • ProcainamideC01BA02severe
  • TocainideC01BB03severe
  • PropylthiouracilH03BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferiprone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferiprone products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Cyprus · Deferiprone Sapiens
  • Denmark · Deferipron Orifarm
  • France · Deferiprone Arrow
  • Greece · Befeprox
  • Iceland · Ferriprox
  • Italy · Deferiprone Doc
  • Liechtenstein · Ferriprox
  • Norway · Ferriprox
  • Portugal · Befeprox, Deferriprona Generis
  • Sweden · Deferipron Evolan, Deferiprone Doc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be6e8c1a-fc89-4eef-b9d6-1f5906387e2d
GET /v1/drugs/be6e8c1a-fc89-4eef-b9d6-1f5906387e2d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3963811000001100",
  "desc": "Ferriprox 500mg tablets (Chiesi Ltd)",
  "form": "Oral tablet",
  "vpid": "41761411000001102",
  "source": "dmd",
  "vtm_id": "775461007",
  "strength": "500 mg",
  "substance": "Deferiprone",
  "ingredient": "Deferiprone",
  "supplier_code": "9052511000001105"
}

See everything about deferiprone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.